FDA.reportPublic FDA data

RIVASTIGMINE

Substance profile for UNII PKI06M3IW0, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for RIVASTIGMINE
Structure render from PubChem CID 77991

Substance Identity#

UNII
PKI06M3IW0
Preferred term
RIVASTIGMINE
Registry number
123441-03-2
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C14H22N2O2
Chemical structure for RIVASTIGMINE
Structure render from PubChem CID 77991

Chemical And Database Identifiers#

InChIKey
XSVMFMHYUFZWBK-NSHDSACASA-N
SMILES
CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C
RxCUI
183379
PubChem
77991
NCIt
C66519
INN ID
7562

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound77991https://pubchem.ncbi.nlm.nih.gov/compound/77991
PubChem InChIKey SearchXSVMFMHYUFZWBK-NSHDSACASA-Nhttps://pubchem.ncbi.nlm.nih.gov/#query=XSVMFMHYUFZWBK-NSHDSACASA-N
RxNorm183379https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=183379
NCI ThesaurusC66519https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C66519
FDA Substance Registration SystemPKI06M3IW0https://precision.fda.gov/uniisearch/srs/unii/PKI06M3IW0

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
RIVASTIGMINEACTIVE INGREDIENTPKI06M3IW0Exelon1
RIVASTIGMINEACTIVE MOIETYPKI06M3IW0Exelon1
RIVASTIGMINEACTIVE MOIETYPKI06M3IW0Rivastigmine Tartrate Capsules1
RIVASTIGMINEACTIVE MOIETYPKI06M3IW0fead084a-a376-4d57-bdf0-aa7ed36555051
RIVASTIGMINEACTIVE MOIETYPKI06M3IW029481887-34eb-460a-bd7f-b8755473065a2
RIVASTIGMINEACTIVE INGREDIENTPKI06M3IW029481887-34eb-460a-bd7f-b8755473065a2
RIVASTIGMINEACTIVE INGREDIENTPKI06M3IW0EXELON (RIVASTIGMINE) PATCH, EXTENDED RELEASE [NOVARTIS PHARMACEUTICALS CORPORATION]16
RIVASTIGMINEACTIVE MOIETYPKI06M3IW0EXELON (RIVASTIGMINE) PATCH, EXTENDED RELEASE [NOVARTIS PHARMACEUTICALS CORPORATION]16
RIVASTIGMINEACTIVE MOIETYPKI06M3IW0EXELON (RIVASTIGMINE TARTRATE) CAPSULE EXELON (RIVASTIGMINE TARTRATE) SOLUTION [NOVARTIS PHARMACEUTICALS CORPORATION]14
RIVASTIGMINEACTIVE MOIETYPKI06M3IW0RIVASTIGMINE TARTRATE CAPSULE [APOTEX CORP.]8
RIVASTIGMINEACTIVE INGREDIENTPKI06M3IW0RIVASTIGMINE TRANSDERMAL SYSTEM PATCH, EXTENDED RELEASE [ALVOGEN INC.]8
RIVASTIGMINEACTIVE MOIETYPKI06M3IW0RIVASTIGMINE TRANSDERMAL SYSTEM PATCH, EXTENDED RELEASE [ALVOGEN INC.]8
RIVASTIGMINEACTIVE MOIETYPKI06M3IW0RIVASTIGMINE TARTRATE CAPSULE [WATSON LABORATORIES, INC.]7
rivastigmineACTIVE MOIETYPKI06M3IW0RIVASTIGMINE TARTRATE (RIVASTIGMINE TARTRATE ) CAPSULE [DR. REDDY'S LABORATORIES LIMITED]6
RIVASTIGMINEACTIVE MOIETYPKI06M3IW0RIVASTIGMINE TARTRATE CAPSULE [BRECKENRIDGE PHARMACEUTICAL, INC]6
RIVASTIGMINEACTIVE MOIETYPKI06M3IW0RIVASTIGMINE TARTRATE CAPSULE [SUN PHARMACEUTICAL INDUSTRIES LIMITED ]5
RIVASTIGMINEACTIVE MOIETYPKI06M3IW0RIVASTIGMINE TARTRATE CAPSULE [CARILION MATERIALS MANAGEMENT]3
RIVASTIGMINEACTIVE MOIETYPKI06M3IW0RIVASTIGMINE TARTRATE CAPSULE [AMERICAN HEALTH PACKAGING]2
RIVASTIGMINEACTIVE MOIETYPKI06M3IW0RIVASTIGMINE TARTRATE CAPSULE [SANDOZ INC]2
RIVASTIGMINEACTIVE MOIETYPKI06M3IW0RIVASTIGMINE PATCH, EXTENDED RELEASE [SANDOZ INC]1
RIVASTIGMINEACTIVE INGREDIENTPKI06M3IW0RIVASTIGMINE PATCH, EXTENDED RELEASE [SANDOZ INC]1
RIVASTIGMINEACTIVE MOIETYPKI06M3IW0RIVASTIGMINE TARTRATE CAPSULE [ALEMBIC PHARMACEUTICALS LIMITED]1
RIVASTIGMINEACTIVE MOIETYPKI06M3IW0RIVASTIGMINE TARTRATE CAPSULE [GOLDEN STATE MEDICAL SUPPLY, INC.]1
RIVASTIGMINEACTIVE MOIETYPKI06M3IW0RIVASTIGMINE TARTRATE CAPSULE [MACLEODS PHARMACEUTICALS LIMITED]1
RIVASTIGMINEACTIVE MOIETYPKI06M3IW0RIVASTIGMINE TARTRATE CAPSULE [MCKESSON PACKAGING SERVICES A BUSINESS UNIT OF MCKESSON CORPORATION]1